In the last trading session, 1.21 million Precigen Inc (NASDAQ:PGEN) shares changed hands as the company’s beta touched 1.72. With the company’s per share price at $0.95 changed hands at -$0.05 or -5.04% during last session, the market valuation stood at $273.21M. PGEN’s last price was a discount, traded about -103.16% off its 52-week high of $1.93. The share price had its 52-week low at $0.79, which suggests the last value was 16.84% up since then. When we look at Precigen Inc’s average trading volume, we note the 10-day average is 0.88 million shares, with the 3-month average coming to 761.97K.

Analysts gave the Precigen Inc (PGEN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended PGEN as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Precigen Inc’s EPS for the current quarter is expected to be -0.08.

Precigen Inc (NASDAQ:PGEN) trade information

Instantly PGEN was in red as seen at the end of in last trading. With action 15.35%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -29.13%, with the 5-day performance at 15.35% in the green. However, in the 30-day time frame, Precigen Inc (NASDAQ:PGEN) is 5.16% up. Looking at the short shares, we see there were 15.36 million shares sold at short interest cover period of 20.43 days.

The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 84.17% from its current market value. According to analyst projections, PGEN’s forecast low is 6 with 6 as the target high. To hit the forecast high, the stock’s price needs a -531.58% plunge from its current level, while the stock would need to soar -531.58% for it to hit the projected low.

Precigen Inc (PGEN) estimates and forecasts

Data shows that the Precigen Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -30.69% over the past 6 months, a -25.71% in annual growth rate that is considerably lower than the industry average of 17.10%. Year-over-year growth is forecast to reach -34.10% down from the last financial year.

Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 1.25M. 4 analysts are of the opinion that Precigen Inc’s revenue for the current quarter will be 1.25M. The company’s revenue for the corresponding quarters a year ago was 1.38M and 1.23M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -9.40%. The estimates for the next quarter sales put growth at 1.80%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 36.94%. The 2024 estimates are for Precigen Inc earnings to decrease by -16.75%, but the outlook for the next 5-year period is at 2.40% per year.

PGEN Dividends

Precigen Inc is expected to release its next quarterly earnings report in December.

Precigen Inc (NASDAQ:PGEN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 10.17% of Precigen Inc shares while 62.79% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 69.91%. There are 62.79% institutions holding the Precigen Inc stock share, with PATIENT CAPITAL MANAGEMENT, LLC the top institutional holder. As of 2024-06-30, the company held 7.2926% of the shares, roughly 18.17 million PGEN shares worth $28.72 million.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 4.1116% or 10.25 million shares worth $16.19 million as of 2024-06-30.